FDA approves Boehringer's blood thinner reversal agent

(Reuters) - U.S. health regulators on Friday approved Praxbind, a reversal agent made by Germany's privately held Boehringer Ingelheim, for use in emergency situations by patients taking the company's widely used Pradaxa blood thinner.